# Travere Therapeutics, Inc.: Form 8-K, filed Sep 10, 2025

- Company: [Travere Therapeutics, Inc.](/companies/tvtx.md) (CIK 1438533)
- Form: 8-K
- Filed: 2025-09-10
- Accepted by EDGAR: Sep 10, 2025, 07:05 ET
- Period: 2025-09-10
- Accession: 0001438533-25-000049
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1438533/000143853325000049/tvtx-20250910.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1438533/000143853325000049/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1438533/000143853325000049/tvtx-20250910.htm

Filed Sep 10, 2025.
Source: SEC EDGAR, the filing index for accession 0001438533-25-000049. Last ingested by Listed: Nov 5, 2026, 14:02 ET. No prices; not investment advice.